TY - JOUR
T1 - Bitopic fluorescent antagonists of the A2A adenosine receptor based on pyrazolo[4,3-
T2 - E] [1,2,4]triazolo[1,5- c] pyrimidin-5-amine functionalized congeners
AU - Duroux, Romain
AU - Ciancetta, Antonella
AU - Mannes, Philip
AU - Yu, Jinha
AU - Boyapati, Shireesha
AU - Gizewski, Elizabeth
AU - Yous, Said
AU - Ciruela, Francisco
AU - Auchampach, John A.
AU - Gao, Zhan Guo
AU - Jacobson, Kenneth A.
N1 - Funding Information:
This research was supported in part by the Intramural Research Program of the NIH, National Institute of Diabetes and Digestive and Kidney Diseases. RD was supported by Inserm, Univ. Lille, France. We thank Dr. John Lloyd (NIDDK) for mass spectroscopy. SB was supported by UGC, India. JA acknowledges support from the National Heart, Lung, and Blood Institute (R01HL133589).
Publisher Copyright:
© 2017 The Royal Society of Chemistry.
PY - 2017
Y1 - 2017
N2 - A pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine antagonist of the A2A adenosine receptor (AR) was functionalized as amine congeners, fluorescent conjugates and a sulfonate, and the A2AAR binding modes were predicted computationally. The optimal n-butyl spacer was incorporated into the following A2AAR-selective (Ki, nM) conjugates: BODIPY630/650 derivative 11 (MRS7396, 24.6) and AlexaFluor488 derivative 12 (MRS7416, 30.3). Flow cytometry of 12 in hA2AAR-expressing HEK-293 cells displayed saturable binding (low nonspecific) and inhibition by known A2AAR antagonists. Water-soluble sulfonate 13 was a highly potent (Ki = 6.2 nM) and selective A2AAR antagonist based on binding and functional assays. Docking and molecular dynamics simulations predicted the regions of interaction of the distal portions of these chain-extended ligands with the A2AAR. The BODIPY630/650 fluorophore of 11 was buried in a hydrophobic interhelical (TM1/TM7) region, while AlexaFluor488 of 12 associated with the hydrophilic extracellular loops. In conclusion, we have identified novel high affinity antagonist probes for A2AAR drug discovery and characterization.
AB - A pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine antagonist of the A2A adenosine receptor (AR) was functionalized as amine congeners, fluorescent conjugates and a sulfonate, and the A2AAR binding modes were predicted computationally. The optimal n-butyl spacer was incorporated into the following A2AAR-selective (Ki, nM) conjugates: BODIPY630/650 derivative 11 (MRS7396, 24.6) and AlexaFluor488 derivative 12 (MRS7416, 30.3). Flow cytometry of 12 in hA2AAR-expressing HEK-293 cells displayed saturable binding (low nonspecific) and inhibition by known A2AAR antagonists. Water-soluble sulfonate 13 was a highly potent (Ki = 6.2 nM) and selective A2AAR antagonist based on binding and functional assays. Docking and molecular dynamics simulations predicted the regions of interaction of the distal portions of these chain-extended ligands with the A2AAR. The BODIPY630/650 fluorophore of 11 was buried in a hydrophobic interhelical (TM1/TM7) region, while AlexaFluor488 of 12 associated with the hydrophilic extracellular loops. In conclusion, we have identified novel high affinity antagonist probes for A2AAR drug discovery and characterization.
UR - http://www.scopus.com/inward/record.url?scp=85027529790&partnerID=8YFLogxK
U2 - 10.1039/c7md00247e
DO - 10.1039/c7md00247e
M3 - Article
AN - SCOPUS:85027529790
SN - 2040-2503
VL - 8
SP - 1659
EP - 1667
JO - MedChemComm
JF - MedChemComm
IS - 8
ER -